Heights Capital Management’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-2,667
Closed -$208K – 435
2022
Q4
$208K Buy
+2,667
New +$155K 0.03% 268

Other funds holding PALI

Heights Capital Management's PALI Position: Q1 2023 in Review

Heights Capital Management sold out of Palisade Bio (PALI) in Q1 2023, closing a stake of 2,667 shares — an estimated $208K sold.

Heights Capital Management first reported a position in PALI in Q4 2022 and held it in 1 quarter. The position peaked at $208K in Q4 2022. 8 funds tracked by Wall St. Rank hold PALI as of Q1 2023.

  • Heights Capital Management reported no remaining Palisade Bio position as of Q1 2023 after selling out during the quarter.
  • Heights Capital Management sold 2,667 Palisade Bio shares in Q1 2023, an estimated $208K.
  • Heights Capital Management first reported a position in Palisade Bio in Q4 2022 and held it in 1 quarter.
  • Heights Capital Management's Palisade Bio position peaked at $208K in Q4 2022.
  • 8 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2023.

Based on Heights Capital Management's 13F filing for Q1 2023, filed 16 May 2023.